By Connor Hart
IDEAYA Biosciences named Joshua Bleharski as its top finance chief, effective in early May.
Bleharski most recently served as managing director and global co-head of biopharma at J.P. Morgan, the South San Francisco, Calif., company said Monday. He held various roles of increasing responsibility over his nearly 17 years at the financial-services firm.
Prior, Bleharski worked as a senior staff scientist at a private biotechnology company in San Diego and was a post-doctoral fellow at the La Jolla Institute for Allergy and Immunology and the UCLA School of Medicine, the company said.
IDEAYA Biosciences said it expects to approve compensation terms of Bleharski, who is 50 years old, at a later date, according to a filing with the Securities and Exchange Commission.
Write to Connor Hart at connor.hart@wsj.com
(END) Dow Jones Newswires
February 10, 2025 06:40 ET (11:40 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。